← Leaderboards
Teresa Rose-Hellekant
University Of Wisconsin Madison
$2,469,392
Attributed
$2,469,392
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $307K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,469,392 · 5
By mechanism
R01$1,506,710 · 1
K01$351,506 · 1
R03$343,876 · 2
R21$267,300 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Jr., Henry C Pitot$4,892,443
- James S. Malter$14,401,668
- Mani S Mahadevan$11,184,338
- Elaine T Alarid$4,708,047
- Catherine Anne Fox$8,592,927
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionLeadGenesResearch PersonnelPreventChemopreventionStem CellsMammary GlandMammary NeoplasmsPreventionTumorBaseMouse ModelChemopreventive AgentMalignant NeoplasmsCellsLaboratory MouseBehaviorBreast Cancer TreatmentAffectBreast Cancer PreventionCell Differentiation ProcessBreastCell Proliferation
Grant awards (15)
Mechanisms by which Short-Term Tamoxifen Chemoprevention Reduces Mammary Cancer$306,761
R01 · FY2015 · CA · contact PI
Mechanisms by which Short-Term Tamoxifen Chemoprevention Reduces Mammary Cancer$297,611
R01 · FY2014 · CA · contact PI
Mechanisms by which Short-Term Tamoxifen Chemoprevention Reduces Mammary Cancer$288,455
R01 · FY2013 · CA · contact PI
Mechanisms by which Short-Term Tamoxifen Chemoprevention Reduces Mammary Cancer$306,917
R01 · FY2012 · CA · contact PI
Mechanisms by which Short-Term Tamoxifen Chemoprevention Reduces Mammary Cancer$306,966
R01 · FY2011 · CA · contact PI
Local Delivery of Breast Cancer Chemopreventives Using Mesenchymal Stem Cells$74,750
R03 · FY2008 · CA · contact PI
Local Delivery of Breast Cancer Chemopreventives Using Mesenchymal Stem Cells$46,633
R03 · FY2008 · CA · contact PI
Local Delivery of Breast Cancer Chemopreventives Using Mesenchymal Stem Cells$74,750
R03 · FY2007 · CA · contact PI
Precancerous Mammary Transcriptome in Mice after Estrog*$72,993
R03 · FY2006 · CA · contact PI
Modulation of a breast cancer pathway by pregnancy$133,650
R21 · FY2005 · CA
Precancerous Mammary Transcriptome in Mice after Estrog*$74,750
R03 · FY2005 · CA
Modulation of a breast cancer pathway by pregnancy$133,650
R21 · FY2004 · CA
GENETIC AND HORMONAL MECHANISMS OF BREAST CANCER$109,969
K01 · FY2002 · RR
GENETIC AND HORMONAL MECHANISMS OF BREAST CANCER$122,005
K01 · FY2001 · RR
GENETIC AND HORMONAL MECHANISMS OF BREAST CANCER$119,532
K01 · FY2000 · RR